Kevin Lanzo

Company: Genentech

Job title: Lead Clinical Scientist, Psychiatry

Seminars:

Panel Discussion: Reviewing the Current Therapeutic Landscape & Pipeline Advances in Neuropsychiatry 8:30 am

Evaluating the latest advancements in psychedelic and non-psychedelic therapeutic development Are the ‘mind altering’ effects of psychedelics necessary for therapeutic action? Exploring new potential treatment options for neuropsychiatric disordersRead more

day: Conference Day One

Workshop B: Enhancing Translational Confidence into Later Stage Clinical Studies with Optimized Psychedelic Biomarker Monitoring 1:00 pm - 4:00 pm

Critical challenges holding back translational development of psychedelic biomarkers include mitigating highly variable subjective measurements and overcoming the lack of clarity on more subtle mood changes. Collaborate with peers to discuss the best approaches to measuring the psychedelic experience: How can we gain deeper understanding of the mechanisms that underlie the downstream signalling effects of…Read more

day: PSYCHEDELIC R&D TRACK